1. Signaling Pathways
  2. GPCR/G Protein
    Immunology/Inflammation
  3. CXCR
  4. CXCR Inhibitors

CXCR Inhibitors

CXCR

CXCR1

CXCR2

CXCR3

CXCR4

CXCR7

CX3CR1

CXCR8

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

CXCR Inhibitors, Agonists, Antagonists & Modulators
Product Name CXCR CXCR1 CXCR2 CXCR3 CXCR4 CXCR7 CX3CR1 CXCR8 Purity
Plerixafor        
125I-CXCL12-CXCR4, IC50: 44 nM
      >98.0%
AMG 487      
125I-IP10-CXCR3, IC50: 8 nM
125I-ITAC-CXCR3, IC50: 8.2 nM
        99.65%
SB225002    
125I-IL-8-CXCR2, IC50: 22 nM (in CHO cell membrane)
          99.78%
Reparixin  
CXCR1wt, IC50: 5.6 nM (in L1.2 cells)
CXCR1Ile43Val, IC50: 80 nM (in L1.2 cells)
CXCR1, IC50: 1 nM (in cells)
CXCR2, IC50: ∼100 nM (in cells)
          99.98%
Plerixafor octahydrochloride        
125I-CXCL12-CXCR4, IC50: 44 nM
      >98.0%
PS372424      
CXCR3
       
Navarixin  
Cynomolgus CXCR1, Kd: 41 nM
Mouse CXCR2, Kd: 0.2 nM
Rat CXCR2, Kd: 0.2 nM
Cynomolgus CXCR2, Kd: 0.08 nM
          98.62%
AZD-5069    
125I-IL-8-CXCR2
          99.92%
AZD8797    
125I-IL-8-CXCR2, Ki: 2800 nM (in HEK293S cells)
     
[125I]-CX3CL1-CX3CR1, Ki: 3.9 nM (in HEK293S cells)
  98.22%
LY2510924        
SDF-1α-CXCR4, IC50: 79.7 pM
SDF-1α-CXCR4, Ki: 49.5 pM
      99.91%
Motixafortide        
CXCR4, IC50: ∼1 nM
      99.19%
Reparixin L-lysine salt  
CXCR1wt, IC50: 5.6 nM (in L1.2 cells)
CXCR1Ile43Val, IC50: 80 nM (in L1.2 cells)
CXCR1, IC50: 1 nM (in cells)
CXCR2, IC50: ∼100 nM (in cells)
          99.97%
Mavorixafor trihydrochloride        
125I-SDF-CXCR4, IC50: 13 nM
      99.14%
TAK-779      
mCXCR3, IC50: 369 nM (in PBMCs)
        99.73%
SCH 546738      
Human CXCR3, Ki: 0.4 nM
        99.23%
Baohuoside I        
CXCR4
      99.70%
IT1t dihydrochloride        
CXCL12/CXCR4, IC50: 2.1 nM
      98.09%
Danirixin    
CXCL8-CXCR2, IC50: 12.5 nM
          98.21%
USL311        
CXCR4
      99.97%
Kynurenic acid              
CXCR8
98.75%
MSX-122        
CXCR4/CXCL12, IC50: ∼10 nM
      98.29%
SCH 563705  
CXCR1, Ki: 3 nM
CXCR1, IC50: 7.3 nM
CXCR2, Ki: 1 nM
CXCR2, IC50: 1.3 nM
Mouse CXCR2, IC50: 5.2 nM
          95.34%
Burixafor hydrobromide        
CXCR4
      >98.0%
JMS-17-2            
CX3CR1, IC50: 0.32 nM
  99.59%
AMD 3465 hexahydrobromide        
2G5 mAb-CXCR4, IC50: 0.75 nM (in SupT1 cells)
CXCL12AF647-CXCR4, IC50: 18 nM (in SupT1 cells)
      98.79%
CXCR2-IN-1    
CXCR2, pIC50: 9.3
          98.81%
E6130            
CX3CR1
  >98.0%
SRT3109    
CXCR2, pIC50: 8.2
          99.82%
NBI-74330      
[125I]CXCL10-CXCR3, Ki: 1.5 nM (in CXCR3-CHO cell membranes)
[125I]CXCL11-CXCR3, Ki: 3.2 nM (in CXCR3-CHO cell membranes)
        >98.0%
IT1t        
CXCL12/CXCR4, IC50: 2.1 nM
     
ALX 40-4C Trifluoroacetate        
SDF-1-CXCR4, Ki: 1 μM
      98.15%
ALX 40-4C        
SDF-1-CXCR4, Ki: 1 μM
     
Mavorixafor        
125I-SDF-CXCR4, IC50: 13 nM
     
SRT3190    
CXCR2
          99.61%
AMD 3465        
2G5 mAb-CXCR4, IC50: 0.75 nM (in SupT1 cells)
CXCL12AF647-CXCR4, IC50: 18 nM (in SupT1 cells)
     
UNBS5162
CXCL
              99.75%
SX-682  
CXCR1
CXCR2
         
CXCR7 modulator 2          
CXCR7, Ki: 13 nM
    >98.0%
GPR35 agonist 1              
CXCR8, EC50: 5.8 nM
Kynurenic acid sodium              
CXCR8
98.60%
CXCR7 modulator 1          
CXCR7, Ki: 9 nM
   
ATI-2341        
CXCR4, EC50: 194 nM (in CCRF-CEM cells)
     
ML 145              
CXCR8, IC50: 20.1 nM
VUF11207 fumarate          
CXCR7, pKi: 8.1